Brief: Sinco Pharmaceuticals Holdings Posts H1 Net Income Of RMB24.4 Mln
27/08/2025 10:01
Aug 27 (Reuters) - Sinco Pharmaceuticals Holdings H1 EPS RMB 0.012. H1 revenue RMB 1,195.8 million H1 gross profit RMB 130.7 million H1 net income RMB 24.4 million
Recent news on Sinco Pharmaceuticals Holdings
See all newsBrief: Sinco Pharmaceuticals Appoints Huang Zhijian As Chairman Of Board
Brief: Sinco Pharmaceuticals Says Huang Xiangbin Tenders Resignation As Chairman, Executive Director
Brief: Sinco Pharmaceuticals Holdings Posts H1 Net Income Of RMB24.4 Mln
Brief: Sinco Pharmaceuticals Says Huang Zhijian Appointed Vice Chairman
Brief: Sinco Pharmaceuticals Says Huang Zhijian Appointed As An Executive Director